[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 3, Multi-center, Open-Label, Randomized, Comparator-Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Bacterial Skin and Skin Structure Infections

What is the purpose of the study? (in Layman's terms, please describe the study)

The purpose of this research study is to determine how well dalbavancin works compared to standard antibiotic treatment (comparator) for ABSSSI in children.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Study Phase:

Phase III

Patient Age Group:


Principal Investigator:

Leonard B Weiner

Who can I contact for more information?

Name: Lori J Ferguson
Phone: 315-464-6331
Email: [email protected]

Return to Previous Page || Search Again